Sacral neuromodulation is not FDA-approved for the treatment of chronic pelvic pain; further studies are needed before it can be recommended for this indication.
WHAT THIS EVIDENCE MEANS FOR PRACTICE
Neither of these studies required objective evidence of myofascial pain for inclusion. Therefore, although the benefits they demonstrated may be theorized to extend to the relief of myofascial pain, this fact cannot be corroborated.
We want to hear from you! Tell us what you think.